Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to assess the effectiveness of once daily application of a diclofenac sodium patch to the skin near or over the painful area. In this study, the location being studied will be one of the following: the affected shoulder, elbow, or wrist.

The secondary purpose of this study is to assess the safety and tolerability of the diclofenac patch on the subject's skin, in the location being studied.


Clinical Trial Description

Cerimon Pharmaceuticals is investigating a topical patch formulation of diclofenac sodium containing 15 mg of diclofenac sodium for the local treatment of acute musculoskeletal pain. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00640939
Study type Interventional
Source Cerimon Pharmaceuticals
Contact
Status Completed
Phase Phase 2/Phase 3
Start date December 2007
Completion date June 2008

See also
  Status Clinical Trial Phase
Completed NCT01330641 - Accuracy of Needle Placement Into The Subacromial Space of The Shoulder N/A